Bending PDUFA’s Cost Curve: PhRMA Looking For Sustainable Program Growth

 
• By Derrick Gingery
  
revenue growth
PDUFA VII likely will continue the current trend of regular program revenue growth. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from User Fees

More from Pathways & Standards